Literature DB >> 10954545

Analysis of Mason-Pfizer monkey virus Gag domains required for capsid assembly in bacteria: role of the N-terminal proline residue of CA in directing particle shape.

M Rumlova-Klikova1, E Hunter, M V Nermut, I Pichova, T Ruml.   

Abstract

Mason-Pfizer monkey virus (M-PMV) preassembles immature capsids in the cytoplasm prior to transporting them to the plasma membrane. Expression of the M-PMV Gag precursor in bacteria results in the assembly of capsids indistinguishable from those assembled in mammalian cells. We have used this system to investigate the structural requirements for the assembly of Gag precursors into procapsids. A series of C- and N-terminal deletion mutants progressively lacking each of the mature Gag domains (matrix protein [MA]-pp24/16-p12-capsid protein [CA]-nucleocapsid protein [NC]-p4) were constructed and expressed in bacteria. The results demonstrate that both the CA and the NC domains are necessary for the assembly of macromolecular arrays (sheets) but that amino acid residues at the N terminus of CA define the assembly of spherical capsids. The role of these N-terminal domains is not based on a specific amino acid sequence, since both MA-CA-NC and p12-CA-NC polyproteins efficiently assemble into capsids. Residues N terminal of CA appear to prevent a conformational change in which the N-terminal proline plays a key role, since the expression of a CA-NC protein lacking this proline results in the assembly of spherical capsids in place of the sheets assembled by the CA-NC protein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10954545      PMCID: PMC116356          DOI: 10.1128/jvi.74.18.8452-8459.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Genetic analysis of interactions between Gag proteins of Rous sarcoma virus.

Authors:  X Li; B Yuan; S P Goff
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus.

Authors:  I Gross; H Hohenberg; H G Kräusslich
Journal:  Eur J Biochem       Date:  1997-10-15

3.  Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagents.

Authors:  J McDermott; L Farrell; R Ross; E Barklis
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles.

Authors:  S Campbell; V M Vogt
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

5.  Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation.

Authors:  Y Zhang; E Barklis
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

6.  Structure of the amino-terminal core domain of the HIV-1 capsid protein.

Authors:  R K Gitti; B M Lee; J Walker; M F Summers; S Yoo; W I Sundquist
Journal:  Science       Date:  1996-07-12       Impact factor: 47.728

7.  Synthesis and assembly of retrovirus Gag precursors into immature capsids in vitro.

Authors:  M Sakalian; S D Parker; R A Weldon; E Hunter
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Efficient in vivo and in vitro assembly of retroviral capsids from Gag precursor proteins expressed in bacteria.

Authors:  M Klikova; S S Rhee; E Hunter; T Ruml
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.

Authors:  S Campbell; V M Vogt
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  The three-dimensional solution structure of the matrix protein from the type D retrovirus, the Mason-Pfizer monkey virus, and implications for the morphology of retroviral assembly.

Authors:  M R Conte; M Klikova; E Hunter; T Ruml; S Matthews
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

View more
  20 in total

1.  Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions.

Authors:  J B Bowzard; J W Wills; R C Craven
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Molecular organization of Mason-Pfizer monkey virus capsids assembled from Gag polyprotein in Escherichia coli.

Authors:  Milan V Nermut; Patrick Bron; Daniel Thomas; Michaela Rumlova; Tomas Ruml; Eric Hunter
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  In vitro assembly of virus-like particles of a gammaretrovirus, the murine leukemia virus XMRV.

Authors:  Romana Hadravová; Alex de Marco; Pavel Ulbrich; Jitka Stokrová; Michal Dolezal; Iva Pichová; Tomás Ruml; John A G Briggs; Michaela Rumlová
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

4.  Conserved and variable features of Gag structure and arrangement in immature retrovirus particles.

Authors:  Alex de Marco; Norman E Davey; Pavel Ulbrich; Judith M Phillips; Vanda Lux; James D Riches; Tibor Fuzik; Tomas Ruml; Hans-Georg Kräusslich; Volker M Vogt; John A G Briggs
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

5.  Nucleic Acid Binding by Mason-Pfizer Monkey Virus CA Promotes Virus Assembly and Genome Packaging.

Authors:  Tibor Füzik; Růžena Píchalová; Florian K M Schur; Karolína Strohalmová; Ivana Křížová; Romana Hadravová; Michaela Rumlová; John A G Briggs; Pavel Ulbrich; Tomáš Ruml
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

6.  Distinct roles for nucleic acid in in vitro assembly of purified Mason-Pfizer monkey virus CANC proteins.

Authors:  Pavel Ulbrich; Sarka Haubova; Milan V Nermut; Eric Hunter; Michaela Rumlova; Tomas Ruml
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Higher-order structure of the Rous sarcoma virus SP assembly domain.

Authors:  Di L Bush; Eric B Monroe; Gregory J Bedwell; Peter E Prevelige; Judith M Phillips; Volker M Vogt
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

8.  Effect of dimerizing domains and basic residues on in vitro and in vivo assembly of Mason-Pfizer monkey virus and human immunodeficiency virus.

Authors:  Karolína Bohmová; Romana Hadravová; Jitka Stokrová; Roman Tuma; Tomás Ruml; Iva Pichová; Michaela Rumlová
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

9.  Conserved cysteines in Mason-Pfizer monkey virus capsid protein are essential for infectious mature particle formation.

Authors:  Růžena Píchalová; Tibor Füzik; Barbora Vokatá; Michaela Rumlová; Manuel Llano; Alžběta Dostálková; Ivana Křížová; Tomáš Ruml; Pavel Ulbrich
Journal:  Virology       Date:  2018-06-12       Impact factor: 3.616

10.  Multimerization of the p12 domain is necessary for Mason-Pfizer monkey virus Gag assembly in vitro.

Authors:  Zdenek Knejzlík; Zdena Smékalová; Tomás Ruml; Michael Sakalian
Journal:  Virology       Date:  2007-05-09       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.